Lung Cancers
34
18
19
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
88.9%
+2.3% vs benchmark
3%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (34)
Bright Light Therapy on Sleep Health in Lung Cancer Patients
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Rapid Autopsy and Procurement of Cancer Tissue
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
Precision Lung Cancer Survivorship Care Intervention
Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea
An Evaluation of Dose-escalation for Intrathoracic Tumours
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer
PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions